Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

CUSIP: 09627Y109

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
65,000,000
Total 13F shares
44,815,573
Share change
+2,763,826
Total reported value
$2,844,822,168
Put/Call ratio
51%
Price per share
$63.48
Number of holders
177
Value change
+$140,175,140
Number of buys
106
Number of sells
73

Quarterly Holders Quick Answers

What is CUSIP 09627Y109?
CUSIP 09627Y109 identifies BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2018

As of 30 Jun 2018, Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by 177 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,815,573 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, OppenheimerFunds, Inc., Hillhouse Capital Management, Ltd., TimesSquare Capital Management, LLC, and PERCEPTIVE ADVISORS LLC. This page lists 177 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.